20 May 2020 2 Min Read
Inovio’s experimental Covid-19 vaccine produces antibodies in mice and guinea pigs
The US immunotherapy company says preliminary results from its human trial, using 40 healthy participants, are expected in June
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In